TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+3.73%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$3.11B
AUM Growth
+$3.11B
(+0.92%)
Cap. Flow
+$26.2M
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
206
New
17
Increased
43
Reduced
39
Closed
34
Top Buys
| 1 |
Rallybio
RLYB
|
$37.6M |
| 2 |
Guardant Health
GH
|
$28.7M |
| 3 |
Idexx Laboratories
IDXX
|
$27.9M |
| 4 |
Amgen
AMGN
|
$23.7M |
| 5 |
AstraZeneca
AZN
|
$21.9M |
Top Sells
| 1 |
Elevance Health
ELV
|
$34.7M |
| 2 |
ResMed
RMD
|
$32.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$22.2M |
| 4 |
DexCom
DXCM
|
$21.8M |
| 5 |
Ascendis Pharma
ASND
|
$13.7M |
Sector Composition
| 1 | Healthcare | 96.51% |
| 2 | Real Estate | 2.72% |
| 3 | Industrials | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.9B
| $36.2M | 1.17% |
181,577
+30,862
| +20% | +$6.15M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.6B
| $35.8M | 1.15% |
189,695
+55,200
| +41% | +$10.4M |
|
|
SGEN
28
DELISTED
Seagen Inc. Common Stock
SGEN
| $35.2M | 1.13% |
207,334
-3,425
| -2% | -$582K |
|
29
Zimmer Biomet
ZBH
$20.8B
| $32.6M | 1.05% |
229,384
| – | – |
|
30
Charles River Laboratories
CRL
$7.99B
| $32.4M | 1.04% |
78,484
+23,810
| +44% | +$9.83M |
|
31
Novavax
NVAX
$1.2B
| $31.4M | 1.01% |
151,491
+63,895
| +73% | +$13.2M |
|
32
Zoetis
ZTS
$67.6B
| $27.7M | 0.89% |
142,597
+86,076
| +152% | +$16.7M |
|
33
HCA Healthcare
HCA
$95.4B
| $27.2M | 0.88% |
111,961
-12,782
| -10% | -$3.1M |
|
34
United Therapeutics
UTHR
$17.7B
| $26.8M | 0.86% |
144,940
+5,502
| +4% | +$1.02M |
|
35
Labcorp
LH
$22.8B
| $26.6M | 0.86% |
110,180
+28,265
| +35% | +$6.83M |
|
36
Icon
ICLR
$14B
| $25.9M | 0.83% |
98,871
+62,514
| +172% | +$16.4M |
|
|
37
DexCom
DXCM
$30.9B
| $23.5M | 0.76% |
171,920
-159,100
| -48% | -$21.8M |
|
|
ONC
38
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $23.1M | 0.75% |
63,772
+17,789
| +39% | +$6.46M |
|
39
Molina Healthcare
MOH
$9.6B
| $22.7M | 0.73% |
83,625
+20,015
| +31% | +$5.43M |
|
40
BioNTech
BNTX
$24.1B
| $22M | 0.71% |
80,757
+23,684
| +41% | +$6.47M |
|
41
Edwards Lifesciences
EW
$47.7B
| $22M | 0.71% |
194,630
-26,925
| -12% | -$3.05M |
|
42
Exact Sciences
EXAS
$9.33B
| $21.5M | 0.69% |
225,282
+25,628
| +13% | +$2.45M |
|
43
Dentsply Sirona
XRAY
$2.77B
| $21.3M | 0.69% |
367,521
-14,823
| -4% | -$860K |
|
|
SYNH
44
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $21.3M | 0.69% |
243,633
| – | – |
|
45
Humana
HUM
$37.5B
| $20.7M | 0.67% |
53,135
-5,000
| -9% | -$1.95M |
|
46
Intuitive Surgical
ISRG
$158B
| $19.9M | 0.64% |
60,006
-3,882
| -6% | -$1.29M |
|
47
Pfizer
PFE
$141B
| $19.4M | 0.62% |
450,379
| – | – |
|
|
CTLT
48
DELISTED
CATALENT, INC.
CTLT
| $19.2M | 0.62% |
143,913
+63,888
| +80% | +$8.5M |
|
49
IQVIA
IQV
$31.4B
| $18.4M | 0.59% |
76,644
+19,878
| +35% | +$4.76M |
|
50
CRISPR Therapeutics
CRSP
$4.82B
| $18.2M | 0.59% |
162,337
| – | – |
|